Gunnar Magnus Modee Persson
Vorsitzender bei INITIATOR PHARMA A/S
Vermögen: 57 795 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Garry Neil | M | 70 | 4 Jahre | |
| Hans Lennart Rudolf Wigzell | M | 86 |
Karolinska Institutet
| 29 Jahre |
| Henrik Kristian Moltke | M | 66 |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 8 Jahre |
| Peter Buhl Jensen | M | 69 |
Medical Prognosis Institute, Inc.
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 16 Jahre |
| Sven Arne Andréasson | M | 72 | 8 Jahre | |
| Christopher Sullivan | M | 40 | 6 Jahre | |
| Magnus Nilsson | M | 68 | 9 Jahre | |
| Gunilla Anders Ekström | M | 66 |
Karolinska Institutet
| 2 Jahre |
| Göran Forsberg | M | 61 | 10 Jahre | |
| Claus Elsborg Olesen | M | 50 | 8 Jahre | |
| Anki Forsberg | F | - |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 25 Jahre |
| Thoas Michael Fioretos | M | 66 | 15 Jahre | |
| Carani Sanjeevi | M | 66 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
Karolinska Institutet
| 28 Jahre |
| Carl Johan Bertil Sundberg | M | 66 |
Karolinska Institutet
| 4 Jahre |
| Steen Meier Knudsen | M | 63 |
Medical Prognosis Institute, Inc.
| - |
| Karin Leandersson | F | 52 | 8 Jahre | |
| Hans Schambye | M | 59 |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | 13 Jahre |
| Christine Lind | F | 50 | 4 Jahre | |
| Theresa Tse | F | 32 | 7 Jahre | |
| Ewa Björling | M | 63 |
Karolinska Institutet
| - |
| June Almenoff | M | 67 | 3 Jahre | |
| Peter Holm | M | 50 | 8 Jahre | |
| Ulf Simonsen | M | 61 | 8 Jahre | |
| Annette Colin Lövgren | F | 59 | 3 Jahre | |
| Flavia Borellini | M | 65 | 4 Jahre | |
| Patricia Delaite | M | 61 | 7 Jahre | |
| Peter Sackey | M | 53 |
Karolinska Institutet
| 4 Jahre |
| Anna-Karin Edstedt Bonamy | M | 50 |
Karolinska Institutet
| 14 Jahre |
| Anna Martling | M | 55 |
Karolinska Institutet
| - |
| Mitchell Chan | M | 43 | 3 Jahre | |
| Alex Valcu | M | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 20 Jahre |
| Thomas Perlmann | M | - |
Karolinska Institutet
| - |
| Han Jing Xie | M | 54 |
Karolinska Institutet
| 4 Jahre |
| Anders Martin-Löf | M | 53 | 6 Jahre | |
| Dino Miano | M | - | - | |
| Gilla Kaplan | M | 76 | 4 Jahre | |
| Daniel Joseph Calvo | M | - |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | - |
| Lars-Olof Hansson | M | 80 |
Karolinska Institutet
| 30 Jahre |
| Mikael Søndergaard Thomsen | M | 56 | 8 Jahre | |
| Damian Marron | M | 62 | 3 Jahre | |
| Björn Cochlovius | M | 56 | 4 Jahre | |
| Johan Rutger Christenson | M | 65 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.
Karolinska Institutet
| 38 Jahre |
| Hans Andreasson | M | 69 |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | - |
| Klas Kärre | M | 70 |
Karolinska Institutet
| - |
| Lajos Gunnar Németh | M | 72 |
Karolinska Institutet
| 21 Jahre |
| Björn Ingemar Odlander | M | 66 |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | 28 Jahre |
| Peter Sjöstrand | M | 78 |
Karolinska Institutet
| - |
| Jan Orwar | M | 60 |
Karolinska Institutet
| - |
| Rolf Lewensohn | M | - |
Karolinska Institutet
| - |
| Johan Dighed | M | 51 | 4 Jahre | |
| Erna Möller | F | - |
Karolinska Institutet
| - |
| John Öhd | M | 53 | 4 Jahre | |
| Carl Samuel Goldfischer | M | 65 |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | 24 Jahre |
| Søren Lemonius | M | 59 |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | - |
| Lars Thorsson | M | 63 | 9 Jahre | |
| Rolf Valter Rikard Kiessling | M | 76 |
Karolinska Institutet
| 30 Jahre |
| Jonas Christopher Frisén | M | 58 |
Karolinska Institutet
| - |
| John Wahren | M | - |
Karolinska Institutet
| - |
| Dorrit T. Andersen | F | - |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | - |
| Anders Olof Adolf Ekblom | M | 70 |
Karolinska Institutet
| - |
| Nanna Liebach Lüneborg | M | 49 |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | - |
| Per M. Almqvist | M | - |
Karolinska Institutet
| - |
| Hans Hassle | M | - |
Karolinska Institutet
| - |
| Søren Møller | M | 56 |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | - |
| Gert Auer | M | - |
Karolinska Institutet
| - |
| Helén Tuvesson | M | 62 | 4 Jahre | |
| Torgny H. Svensson | M | - |
Karolinska Institutet
| - |
| Erik Gustav Magnus Axelson | M | - |
Karolinska Institutet
| - |
| Lars Olov Larsson | M | - |
Karolinska Institutet
| - |
| Lars Gunnar Lannfelt | M | 75 |
Karolinska Institutet
| 31 Jahre |
| Torkel Klingberg | M | - |
Karolinska Institutet
| - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Simon Pedder | M | 63 | 2 Jahre | |
| Blake Paterson | M | 67 | 4 Jahre | |
| Uli Alf Hacksell | M | 74 | 5 Jahre | |
| Sijme Zeilemaker | M | 37 | 4 Jahre | |
| James Harrell | M | 54 | 4 Jahre | |
| Robert C. Moscato | M | 48 | 1 Jahre | |
| James Cullem | M | 56 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | 4 Jahre |
| Carlos de Sousa | M | 66 | 3 Jahre | |
| Frank Knudsen | M | 66 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | - |
| Isaac Blech | M | 73 | 8 Jahre | |
| Steven Boyd | M | 43 | 5 Jahre | |
| Joseph Miller | M | 50 | 4 Jahre | |
| Federica O’Brien | F | 66 | 2 Jahre | |
| Sol Barer | M | 76 | 1 Jahre | |
| Jim van Heusden | M | 53 | 2 Jahre | |
| Michael Cola | M | 64 | 2 Jahre | |
| Michael Oredsson | M | 64 | 3 Jahre | |
| Thomas H. Aasen | M | 63 | 1 Jahre | |
| Eugene Bauer | M | 81 | 2 Jahre | |
| Bernadine Heather Fraser | M | 55 | - | |
| Ronald Marcus | M | 65 | 2 Jahre | |
| Kerstin Valinder-Strinnholm | F | 64 | 4 Jahre | |
| Karl Härfstrand | M | 66 | 2 Jahre | |
| Jamal El-Mosleh | M | 43 | 9 Jahre | |
| Ulf Göran Richenberg | M | 69 | 12 Jahre | |
| H. Wilkins | M | 62 | - | |
| Fredrik Järrsten | M | 57 | 4 Jahre | |
| Michael Barrett | M | 81 | - | |
| Frank Torti | M | 45 | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Schweden | 60 | 60,00% |
| Vereinigte Staaten | 26 | 26,00% |
| Dänemark | 17 | 17,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Gunnar Magnus Modee Persson
- Persönliches Netzwerk
